OR

Browse By

Therapeutic treatment of tau transgenic mice with a novel N-terminal tau-specific monoclonal antibody (2018–2019)

Grant type:
The Mason Foundation National Medical Program
Funded by:
Equity Trustees Wealth Services Limited